Regeneron’s CEO, CSO saw their compensation slashed in ’16 — but it’s still a jaw-dropping sum
Regeneron has long set the pace for setting aside the richest annual pay packages in the biotech industry for its outspoken CEO Len Schleifer and R&D chief George Yancopoulos. And in 2016 they brought home a mother lode of wealth — which still fell far short of what they made in the previous two years.
On Tuesday the biotech $REGN filed their proxy statement with the SEC, and the outspoken Schleifer came out with a full compensation award of $28.3 million built on an annual salary of $1.25 million. His CSO Yancopoulos earned compensation totaling a very close $27.8 million.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.